Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alba A Brandes

Showing results (71-80 of 178) with videos related to

Pageof 18
Sort By:
Anticancer Research|May 7, 2017
EAGLES study: First-line Bevacizumab in Combination with Chemotherapy in Elderly Patients with Advanced, Metastatic, Non-squamous Non-small Cell Lung CancerFilippo DE Marinis, Paolo Bidoli, Andrea Luciani, et al.
Expert Review of Anticancer Therapy|August 18, 2020
Treatment of recurrent glioblastoma: state-of-the-art and future perspectivesVincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 2009
EORTC study 26041-22041: phase I/II study on concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) with PTK787/ZK222584 (PTK/ZK) in newly diagnosed glioblastomaAlba A Brandes, Roger Stupp, Peter Hau, et al.
Oncology|August 21, 2002
Temozolomide in patients with glioblastoma at second relapse after first line nitrosourea-procarbazine failure: a phase II studyAlba A Brandes, Mario Ermani, Umberto Basso, et al.
Journal of Neuro-Oncology|July 28, 2017
Non-canonical IDH1 and IDH2 mutations: a clonal and relevant event in an Italian cohort of gliomas classified according to the 2016 World Health Organization (WHO) criteriaMichela Visani, Giorgia Acquaviva, Gianluca Marucci, et al.
Cancer Chemotherapy and Pharmacology|January 27, 2009
Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)Alba A Brandes, A Tosoni, E Franceschi, et al.
European Journal of Cancer (Oxford, England : 1990)|November 6, 2018
Safety profile of subcutaneous trastuzumab for the treatment of patients with HER2-positive early or locally advanced breast cancer: primary analysis of the SCHEARLY studyMilvia Zambetti, Filippo Montemurro, Paolo Morandi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2004
First-line chemotherapy with cisplatin plus fractionated temozolomide in recurrent glioblastoma multiforme: a phase II study of the Gruppo Italiano Cooperativo di Neuro-OncologiaAlba A Brandes, Umberto Basso, Michele Reni, et al.
Tumori|April 25, 2015
A commentary on interstitial pneumonitis induced by docetaxel: clinical cases and systematic review of the literatureGiovenzio Genestreti, Monica Di Battista, Rocco Trisolini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 7, 2006
Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO studyAlba A Brandes, Alicia Tosoni, Giovanna Cavallo, et al.
Pageof 18

Showing results (71-80 of 178) with videos related to

Sort By:
Pageof 18
Anticancer Research|May 7, 2017
EAGLES study: First-line Bevacizumab in Combination with Chemotherapy in Elderly Patients with Advanced, Metastatic, Non-squamous Non-small Cell Lung CancerFilippo DE Marinis, Paolo Bidoli, Andrea Luciani, et al.
Expert Review of Anticancer Therapy|August 18, 2020
Treatment of recurrent glioblastoma: state-of-the-art and future perspectivesVincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 2009
EORTC study 26041-22041: phase I/II study on concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) with PTK787/ZK222584 (PTK/ZK) in newly diagnosed glioblastomaAlba A Brandes, Roger Stupp, Peter Hau, et al.
Oncology|August 21, 2002
Temozolomide in patients with glioblastoma at second relapse after first line nitrosourea-procarbazine failure: a phase II studyAlba A Brandes, Mario Ermani, Umberto Basso, et al.
Journal of Neuro-Oncology|July 28, 2017
Non-canonical IDH1 and IDH2 mutations: a clonal and relevant event in an Italian cohort of gliomas classified according to the 2016 World Health Organization (WHO) criteriaMichela Visani, Giorgia Acquaviva, Gianluca Marucci, et al.
Cancer Chemotherapy and Pharmacology|January 27, 2009
Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)Alba A Brandes, A Tosoni, E Franceschi, et al.
European Journal of Cancer (Oxford, England : 1990)|November 6, 2018
Safety profile of subcutaneous trastuzumab for the treatment of patients with HER2-positive early or locally advanced breast cancer: primary analysis of the SCHEARLY studyMilvia Zambetti, Filippo Montemurro, Paolo Morandi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2004
First-line chemotherapy with cisplatin plus fractionated temozolomide in recurrent glioblastoma multiforme: a phase II study of the Gruppo Italiano Cooperativo di Neuro-OncologiaAlba A Brandes, Umberto Basso, Michele Reni, et al.
Tumori|April 25, 2015
A commentary on interstitial pneumonitis induced by docetaxel: clinical cases and systematic review of the literatureGiovenzio Genestreti, Monica Di Battista, Rocco Trisolini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 7, 2006
Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO studyAlba A Brandes, Alicia Tosoni, Giovanna Cavallo, et al.
Pageof 18